Wednesday, May 07, 2025 11:07:39 AM
OT: Did you read this huge PLUG release? Plug Power Closes $525 Million Secured Credit Facility with Yorkville Advisors
Plug to Hold First Quarter 2025 Earnings Call on May 12, 2025
SLINGERLANDS, N.Y., May 06, 2025 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions, today announced the initial closing of its previously announced $525 million secured term loan facility with Yorkville Advisors. The initial tranche in an aggregate principal amount of $210 million was drawn and funded. Commensurate with establishing this facility, the company has retired $82.5 million in aggregate principal of the existing convertible debenture with Yorkville Advisors, which had approximately 55 million associated underlying shares given the conversion price, and therefore this refinancing has reduced potential dilution. The transaction enhances Plug’s liquidity position and provides the company with additional financial flexibility as it continues to scale its green hydrogen network and drive toward profitability.
“This financing provides meaningful capital to support Plug’s strategic priorities in 2025 and beyond,” said Andy Marsh, CEO of Plug. “We appreciate the confidence Yorkville has shown in our long-term vision and are pleased to have closed this deal under favorable terms for the company.”
Plug will provide further details during its upcoming first quarter 2025 earnings call.
Q1 2025 Earnings Conference Call Details:
Plug’s First Quarter 2025 results will be released on Monday, May 12, 2025.
Join the call
Time: 4:30 pm ET
Participant Dial-In: 877-407-9221 / +1 201-689-8597
Webcast: https://event.webcasts.com/starthere.jsp?ei=1718659&tp_key=e4fec597b7
A live webcast will be available on the Plug Investor Relations website at https://www.ir.plugpower.com, and a playback will be available online for a period of time following the call.
Plug to Hold First Quarter 2025 Earnings Call on May 12, 2025
SLINGERLANDS, N.Y., May 06, 2025 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions, today announced the initial closing of its previously announced $525 million secured term loan facility with Yorkville Advisors. The initial tranche in an aggregate principal amount of $210 million was drawn and funded. Commensurate with establishing this facility, the company has retired $82.5 million in aggregate principal of the existing convertible debenture with Yorkville Advisors, which had approximately 55 million associated underlying shares given the conversion price, and therefore this refinancing has reduced potential dilution. The transaction enhances Plug’s liquidity position and provides the company with additional financial flexibility as it continues to scale its green hydrogen network and drive toward profitability.
“This financing provides meaningful capital to support Plug’s strategic priorities in 2025 and beyond,” said Andy Marsh, CEO of Plug. “We appreciate the confidence Yorkville has shown in our long-term vision and are pleased to have closed this deal under favorable terms for the company.”
Plug will provide further details during its upcoming first quarter 2025 earnings call.
Q1 2025 Earnings Conference Call Details:
Plug’s First Quarter 2025 results will be released on Monday, May 12, 2025.
Join the call
Time: 4:30 pm ET
Participant Dial-In: 877-407-9221 / +1 201-689-8597
Webcast: https://event.webcasts.com/starthere.jsp?ei=1718659&tp_key=e4fec597b7
A live webcast will be available on the Plug Investor Relations website at https://www.ir.plugpower.com, and a playback will be available online for a period of time following the call.
Recent PHIO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:23:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:16:06 PM
- Phio Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update • Newsfile • 05/07/2026 08:05:00 PM
- Phio Pharmaceuticals Announces "Nobel Prize Winning Science Takes on Skin Cancer" in a Fireside Chat with Force Family Office on Wednesday, April 15, 2026 • Newsfile • 04/13/2026 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/08/2026 08:15:54 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/08/2026 08:13:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 11:15:34 AM
- Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762 • Newsfile • 03/30/2026 11:00:00 AM
- Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancement • Newsfile • 03/23/2026 11:00:00 AM
- Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office • Newsfile • 03/16/2026 03:30:00 PM
- Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 03/13/2026 12:35:00 PM
- Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th • GlobeNewswire Inc. • 03/10/2026 02:21:44 PM
- Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT • GlobeNewswire Inc. • 03/10/2026 12:35:00 PM
- Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT • GlobeNewswire Inc. • 03/10/2026 11:59:39 AM
- Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026, 11 AM EDT • Newsfile • 03/10/2026 11:00:00 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2026 09:17:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 09:10:23 PM
- Phio Pharmaceuticals Reports 2025 Year-End Financial Results and Business Update • Newsfile • 03/05/2026 09:05:00 PM
- Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series • Newsfile • 03/05/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 09:01:20 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 07:49:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/10/2026 12:33:55 PM
- Phio Announces Safety Monitoring Committee's (SMC) Positive Wrap-up on Lead Clinical Candidate PH-762 in Skin Cancer Trial • Newsfile • 02/10/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 01:00:21 PM
